Nautilus Biotechnolgy (NAUT)

• Market cap: $91.2M
• 1 day: -2.91%
• 5 days: 6.81%
• 1 month: 11.11%
• 3 months: -52.10%
• 6 months: -64.29%
• Year to date: -52.66%
• 1 year: -71.83%
• 5 years: -92.34%
• 10 years: -92.34%
• Sector: Healthcare
• Industry: Biotechnology

About: Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Employees: 155

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

400% more call options, than puts

Call options by funds: $25K | Put options by funds: $5K

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

0% more funds holding in top 10

Funds holding in top 10: 3 [Q4 2024] → 3 (+0) [Q1 2025]

1.19% less ownership

Funds ownership: 50.86% [Q4 2024] → 49.67% (-1.19%) [Q1 2025]

2% less funds holding

Funds holding: 86 [Q4 2024] → 84 (-2) [Q1 2025]

43% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 30

50% less capital invested

Capital invested by funds: $107M [Q4 2024] → $54M (-$53.3M) [Q1 2025]